X-LINKED CHARCOT-MARIE-TOOTH DISEASE
Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathy (HMSN), is a heterogeneous group of dominantly inherited peripheral neuropathies that are all characterized by a chronic, progressive course. CMT was first described in 1886 by Charcot and Marie (1886) and independently by Tooth (1886), and an X-linked family was described by Herringham (1889) shortly thereafter. CMT causes slowly progressive weakness and atrophy of the distal limb muscles, as well as pes cavus, sensory loss, and loss of deep tendon reflexes. On the basis of clinical features, nerve conduction velocities, and histopathology, CMT was subdivided into two types (Dyck & Lambert, 1968a,b) -type 1 (demyelinating) and type 2 (axonal). Linkage studies led to the further subdivision of CMT1 into four genetic forms: CMT1A (linked to chromosome 17), CMT1B (linked to chromosome 1), CMTX (linked to the X chromosome), and CMT1C (not linked to chromosome 1, 17, or X).
CMT affects about 1/3000 individuals, of which 10-20% have CMTX, making it the second most common form of CMT after CMT1A (Ionasescu et al., 1993; Skre, 1974) . In males, symptoms begin in late childhood or adolescence and progress to moderate disability by the third decade of life (for review, see Deschênes et al., 1996) . Female carriers are usually less severely affected than affected males at the same age and may be clinically asymptomatic, although even asymptomatic women may have decreased nerve conduction velocities. Nerve biopsies of CMTX patients show both axonal loss and remyelination (Hahn et al., 1990; Rozear et al., 1987) , and nerve conduction velocities are modestly slowed-between 25 and 40 m/s for affected males and 25 and 50 m/s for heterozygous
